Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
Grade 1, 2, or 3a FL without pathologic evidence of transformation
Male and female, ages 18 and above, with relapsed or refractory FL lymphoma after \> or =2 prior treatment lines; each of the 2 prior treatment lines must include at least CD20 antibody and/or an alkylating agent
Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0-1
You may not be if
Known central nervous system lymphoma
History of interstitial lung disease
Subjects with active, known or suspected autoimmune disease
Prior allogeneic stem cell transplant
Prior autologous stem cell transplant ≤12 weeks prior to first dose of study drug
